Abstract
Summary
Phenylpropanolamine (PPA) is a sympathomimetic agent which is used as a decongestant and appetite suppressant. It was commonly used in prescription and over-the-counter cough and cold preparations. In veterinary medicine, it is used to control urinary incontinence in dogs
The global market for Phenylpropanolamine was estimated to be worth US$ 1569 million in 2023 and is forecast to a readjusted size of US$ 2185.2 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phenylpropanolamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Phenylpropanolamine by region & country, by Type, and by Application.
The Phenylpropanolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylpropanolamine.
Market Segmentation
By Company
Riemser Pharma
Abbott
Gräub
Helicon
Eipico
Schazoo
GlaxoSmithKline (GSK)
Roemmers
Armoxindo
Asuncion
Medlink
Sanofi-Aventis
Tempo Scan Pacific
Carinopharm
Meda
IBL Healthcare
Gracia Pharmindo
Segment by Type:
Tablet
Capsule
Syrup
Segment by Application
Human
Veterinary
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Phenylpropanolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Phenylpropanolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Phenylpropanolamine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Phenylpropanolamine was estimated to be worth US$ 1569 million in 2023 and is forecast to a readjusted size of US$ 2185.2 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phenylpropanolamine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Phenylpropanolamine by region & country, by Type, and by Application.
The Phenylpropanolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylpropanolamine.
Market Segmentation
By Company
Riemser Pharma
Abbott
Gräub
Helicon
Eipico
Schazoo
GlaxoSmithKline (GSK)
Roemmers
Armoxindo
Asuncion
Medlink
Sanofi-Aventis
Tempo Scan Pacific
Carinopharm
Meda
IBL Healthcare
Gracia Pharmindo
Segment by Type:
Tablet
Capsule
Syrup
Segment by Application
Human
Veterinary
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Phenylpropanolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Phenylpropanolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Phenylpropanolamine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Phenylpropanolamine Product Introduction
1.2 Global Phenylpropanolamine Market Size Forecast
1.2.1 Global Phenylpropanolamine Sales Value (2019-2030)
1.2.2 Global Phenylpropanolamine Sales Volume (2019-2030)
1.2.3 Global Phenylpropanolamine Sales Price (2019-2030)
1.3 Phenylpropanolamine Market Trends & Drivers
1.3.1 Phenylpropanolamine Industry Trends
1.3.2 Phenylpropanolamine Market Drivers & Opportunity
1.3.3 Phenylpropanolamine Market Challenges
1.3.4 Phenylpropanolamine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Phenylpropanolamine Players Revenue Ranking (2023)
2.2 Global Phenylpropanolamine Revenue by Company (2019-2024)
2.3 Global Phenylpropanolamine Players Sales Volume Ranking (2023)
2.4 Global Phenylpropanolamine Sales Volume by Company Players (2019-2024)
2.5 Global Phenylpropanolamine Average Price by Company (2019-2024)
2.6 Key Manufacturers Phenylpropanolamine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Phenylpropanolamine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Phenylpropanolamine
2.9 Phenylpropanolamine Market Competitive Analysis
2.9.1 Phenylpropanolamine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Phenylpropanolamine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylpropanolamine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet
3.1.2 Capsule
3.1.3 Syrup
3.2 Global Phenylpropanolamine Sales Value by Type
3.2.1 Global Phenylpropanolamine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Phenylpropanolamine Sales Value, by Type (2019-2030)
3.2.3 Global Phenylpropanolamine Sales Value, by Type (%) (2019-2030)
3.3 Global Phenylpropanolamine Sales Volume by Type
3.3.1 Global Phenylpropanolamine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Phenylpropanolamine Sales Volume, by Type (2019-2030)
3.3.3 Global Phenylpropanolamine Sales Volume, by Type (%) (2019-2030)
3.4 Global Phenylpropanolamine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Human
4.1.2 Veterinary
4.2 Global Phenylpropanolamine Sales Value by Application
4.2.1 Global Phenylpropanolamine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Phenylpropanolamine Sales Value, by Application (2019-2030)
4.2.3 Global Phenylpropanolamine Sales Value, by Application (%) (2019-2030)
4.3 Global Phenylpropanolamine Sales Volume by Application
4.3.1 Global Phenylpropanolamine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Phenylpropanolamine Sales Volume, by Application (2019-2030)
4.3.3 Global Phenylpropanolamine Sales Volume, by Application (%) (2019-2030)
4.4 Global Phenylpropanolamine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Phenylpropanolamine Sales Value by Region
5.1.1 Global Phenylpropanolamine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Phenylpropanolamine Sales Value by Region (2019-2024)
5.1.3 Global Phenylpropanolamine Sales Value by Region (2025-2030)
5.1.4 Global Phenylpropanolamine Sales Value by Region (%), (2019-2030)
5.2 Global Phenylpropanolamine Sales Volume by Region
5.2.1 Global Phenylpropanolamine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Phenylpropanolamine Sales Volume by Region (2019-2024)
5.2.3 Global Phenylpropanolamine Sales Volume by Region (2025-2030)
5.2.4 Global Phenylpropanolamine Sales Volume by Region (%), (2019-2030)
5.3 Global Phenylpropanolamine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Phenylpropanolamine Sales Value, 2019-2030
5.4.2 North America Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Phenylpropanolamine Sales Value, 2019-2030
5.5.2 Europe Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Phenylpropanolamine Sales Value, 2019-2030
5.6.2 Asia Pacific Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Phenylpropanolamine Sales Value, 2019-2030
5.7.2 South America Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Phenylpropanolamine Sales Value, 2019-2030
5.8.2 Middle East & Africa Phenylpropanolamine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Phenylpropanolamine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Phenylpropanolamine Sales Value
6.2.1 Key Countries/Regions Phenylpropanolamine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Phenylpropanolamine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Phenylpropanolamine Sales Value, 2019-2030
6.3.2 United States Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Phenylpropanolamine Sales Value, 2019-2030
6.4.2 Europe Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Phenylpropanolamine Sales Value, 2019-2030
6.5.2 China Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Phenylpropanolamine Sales Value, 2019-2030
6.6.2 Japan Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Phenylpropanolamine Sales Value, 2019-2030
6.7.2 South Korea Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Phenylpropanolamine Sales Value, 2019-2030
6.8.2 Southeast Asia Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Phenylpropanolamine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Phenylpropanolamine Sales Value, 2019-2030
6.9.2 India Phenylpropanolamine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Phenylpropanolamine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Riemser Pharma
7.1.1 Riemser Pharma Company Information
7.1.2 Riemser Pharma Introduction and Business Overview
7.1.3 Riemser Pharma Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Riemser Pharma Phenylpropanolamine Product Offerings
7.1.5 Riemser Pharma Recent Development
7.2 Abbott
7.2.1 Abbott Company Information
7.2.2 Abbott Introduction and Business Overview
7.2.3 Abbott Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Phenylpropanolamine Product Offerings
7.2.5 Abbott Recent Development
7.3 Gräub
7.3.1 Gräub Company Information
7.3.2 Gräub Introduction and Business Overview
7.3.3 Gräub Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Gräub Phenylpropanolamine Product Offerings
7.3.5 Gräub Recent Development
7.4 Helicon
7.4.1 Helicon Company Information
7.4.2 Helicon Introduction and Business Overview
7.4.3 Helicon Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Helicon Phenylpropanolamine Product Offerings
7.4.5 Helicon Recent Development
7.5 Eipico
7.5.1 Eipico Company Information
7.5.2 Eipico Introduction and Business Overview
7.5.3 Eipico Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Eipico Phenylpropanolamine Product Offerings
7.5.5 Eipico Recent Development
7.6 Schazoo
7.6.1 Schazoo Company Information
7.6.2 Schazoo Introduction and Business Overview
7.6.3 Schazoo Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Schazoo Phenylpropanolamine Product Offerings
7.6.5 Schazoo Recent Development
7.7 GlaxoSmithKline (GSK)
7.7.1 GlaxoSmithKline (GSK) Company Information
7.7.2 GlaxoSmithKline (GSK) Introduction and Business Overview
7.7.3 GlaxoSmithKline (GSK) Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 GlaxoSmithKline (GSK) Phenylpropanolamine Product Offerings
7.7.5 GlaxoSmithKline (GSK) Recent Development
7.8 Roemmers
7.8.1 Roemmers Company Information
7.8.2 Roemmers Introduction and Business Overview
7.8.3 Roemmers Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Roemmers Phenylpropanolamine Product Offerings
7.8.5 Roemmers Recent Development
7.9 Armoxindo
7.9.1 Armoxindo Company Information
7.9.2 Armoxindo Introduction and Business Overview
7.9.3 Armoxindo Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Armoxindo Phenylpropanolamine Product Offerings
7.9.5 Armoxindo Recent Development
7.10 Asuncion
7.10.1 Asuncion Company Information
7.10.2 Asuncion Introduction and Business Overview
7.10.3 Asuncion Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Asuncion Phenylpropanolamine Product Offerings
7.10.5 Asuncion Recent Development
7.11 Medlink
7.11.1 Medlink Company Information
7.11.2 Medlink Introduction and Business Overview
7.11.3 Medlink Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Medlink Phenylpropanolamine Product Offerings
7.11.5 Medlink Recent Development
7.12 Sanofi-Aventis
7.12.1 Sanofi-Aventis Company Information
7.12.2 Sanofi-Aventis Introduction and Business Overview
7.12.3 Sanofi-Aventis Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Sanofi-Aventis Phenylpropanolamine Product Offerings
7.12.5 Sanofi-Aventis Recent Development
7.13 Tempo Scan Pacific
7.13.1 Tempo Scan Pacific Company Information
7.13.2 Tempo Scan Pacific Introduction and Business Overview
7.13.3 Tempo Scan Pacific Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Tempo Scan Pacific Phenylpropanolamine Product Offerings
7.13.5 Tempo Scan Pacific Recent Development
7.14 Carinopharm
7.14.1 Carinopharm Company Information
7.14.2 Carinopharm Introduction and Business Overview
7.14.3 Carinopharm Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Carinopharm Phenylpropanolamine Product Offerings
7.14.5 Carinopharm Recent Development
7.15 Meda
7.15.1 Meda Company Information
7.15.2 Meda Introduction and Business Overview
7.15.3 Meda Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Meda Phenylpropanolamine Product Offerings
7.15.5 Meda Recent Development
7.16 IBL Healthcare
7.16.1 IBL Healthcare Company Information
7.16.2 IBL Healthcare Introduction and Business Overview
7.16.3 IBL Healthcare Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 IBL Healthcare Phenylpropanolamine Product Offerings
7.16.5 IBL Healthcare Recent Development
7.17 Gracia Pharmindo
7.17.1 Gracia Pharmindo Company Information
7.17.2 Gracia Pharmindo Introduction and Business Overview
7.17.3 Gracia Pharmindo Phenylpropanolamine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Gracia Pharmindo Phenylpropanolamine Product Offerings
7.17.5 Gracia Pharmindo Recent Development
8 Industry Chain Analysis
8.1 Phenylpropanolamine Industrial Chain
8.2 Phenylpropanolamine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Phenylpropanolamine Sales Model
8.5.2 Sales Channel
8.5.3 Phenylpropanolamine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer